Showing results (101-110 of 1,917) with videos related to

Sort By:
Pageof 192
CNS & Neurological Disorders Drug Targets|August 8, 2019
Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced MiceXinxin Fu, Tingting Qin, Jiayu Yu, et al.
CNS & Neurological Disorders Drug Targets|October 6, 2022
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic ReviewAdina Stan, Hanna Dragos, Stefan Strilciuc, et al.
CNS & Neurological Disorders Drug Targets|February 12, 2021
The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?Aboagyewaah Oppong-Damoah, Brenda Marie Gannon, Kevin Sean Murnane
CNS & Neurological Disorders Drug Targets|February 19, 2021
Parkinson's Disease: Is there a Role for Dietary and Herbal Supplements?Olakunle J Onaolapo, Ademola O Odeniyi, Adejoke Y Onaolapo
CNS & Neurological Disorders Drug Targets|March 10, 2021
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 PandemicSumit Sharma, Sonali Batra, Saurabh Gupta, et al.
CNS & Neurological Disorders Drug Targets|March 10, 2021
Deciphering the Influence of Cigarette Smoke Carcinogens on CNS Associated Biomolecules: A Computational Synergistic ApproachQazi M S Jamal, Ali H Alharbi, Anupam Dhasmana, et al.
CNS & Neurological Disorders Drug Targets|December 28, 2021
Speech as a Biomarker for DepressionSanne Koops, Sanne G Brederoo, Janna N de Boer, et al.
CNS & Neurological Disorders Drug Targets|December 30, 2021
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A PerspectiveVishal Chavda, Arif Tasleem Jan, Dhananjay Yadav
CNS & Neurological Disorders Drug Targets|December 31, 2021
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson's Disease - An UpdateZhi Xin Chew, Chooi Ling Lim, Khuen Yen Ng, et al.
CNS & Neurological Disorders Drug Targets|January 19, 2022
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis DiseaseMaedeh Eslahi, Negin Nematbakhsh, Narges Dastmalchi, et al.
Pageof 192